Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update

被引:155
|
作者
Dale, William [1 ]
Klepin, Heidi D. [2 ]
Williams, Grant R. [3 ]
Alibhai, Shabbir M. H. [4 ]
Bergerot, Cristiane [5 ]
Brintzenhofeszoc, Karlynn [6 ]
Hopkins, Judith O. [7 ]
Jhawer, Minaxi P. [8 ]
Katheria, Vani [9 ]
Loh, Kah Poh [10 ]
Lowenstein, Lisa M. [11 ]
Mckoy, June M. [12 ]
Noronha, Vanita [13 ]
Phillips, Tanyanika [14 ]
Rosko, Ashley E. [15 ]
Ruegg, Tracy [16 ]
Schiaffino, Melody K. [17 ]
Simmons, John F. [18 ]
Subbiah, Ishwaria [19 ]
Tew, William P. [20 ]
Webb, Tracy L. [21 ]
Whitehead, Mary [22 ]
Somerfield, Mark R. [23 ]
Mohile, Supriya G. [10 ,24 ]
机构
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Wake Forest Baptist Comprehens Canc Ctr, Winston Salem, NC USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] CETTRO Canc Res Hosp Brasilia, Brasilia, Brazil
[6] Univ Louisville, Kent Sch Social Work, Louisville, KY USA
[7] SCOR NCORP, Novant Hlth Canc Inst, Winston Salem, NC USA
[8] Englewood Hlth, Englewood, NJ USA
[9] City Hope Comprehens Canc Ctr, Duarte, CA USA
[10] Univ Rochester, Med Ctr, Rochester, NY USA
[11] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[12] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[13] Tata Mem Hosp, Mumbai, India
[14] City Hope Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA
[15] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[16] Kennesaw State Univ, WellStar Sch Nursing, Kennesaw, GA USA
[17] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA
[18] SCOREboard, Oakland, CA USA
[19] MD Anderson Canc Ctr, Houston, TX USA
[20] Mem Sloan Kettering Canc Ctr, New York, NY USA
[21] Wake Forest Univ Hlth Sci, Winston Salem, NC USA
[22] SCOREboard, Sharon, CT USA
[23] Amer Soc Clin Oncol, Alexandria, VA USA
[24] Amer Soc Clin Oncol, 2318 Mill Rd, Suite 800, Alexandria, VA 22314 USA
关键词
COMPREHENSIVE GERIATRIC ASSESSMENT; QUALITY-OF-LIFE; ADULTS AGED 65; CHEMOTHERAPY TOXICITY; AMERICAN SOCIETY; CLINICAL-TRIALS; GAIT SPEED; MINI-COG; SURVIVAL; VALIDATION;
D O I
10.1200/JCO.23.00933
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSETo update the ASCO guideline (2018) on the practical assessment and management of age-associated vulnerabilities in older patients undergoing systemic cancer therapy.METHODSAn Expert Panel conducted a systematic review to identify relevant randomized clinical trials (RCTs), systematic reviews, and meta-analyses from January 2016 to December 2022.RESULTSA total of 26 publications met eligibility criteria and form the evidentiary basis for the update.RECOMMENDATIONSThe Expert Panel reiterates its overarching recommendation from the prior guideline that geriatric assessment (GA), including all essential domains, should be used to identify vulnerabilities or impairments that are not routinely captured in oncology assessments for all patients over 65 years old with cancer. Based on recently published RCTs demonstrating significantly improved clinical outcomes, all older adults with cancer (65+ years old) receiving systemic therapy with GA-identified deficits should have GA-guided management (GAM) included in their care plan. GAM includes using GA findings to inform cancer treatment decision-making as well as to address impairments through appropriate interventions, counseling, and/or referrals. A GA should include high priority aging-related domains known to be associated with outcomes in older adults with cancer: physical and cognitive function, emotional health, comorbid conditions, polypharmacy, nutrition, and social support. Clinical adaptation of the GA based on patient population, resources, and time is appropriate.The Panel recommends the Practical Geriatric Assessment as one option for this purpose (https://old-prod.asco.org/sites/new-www.asco.org/files/content-files/practice-patients/documents/2023-PGA-Final.pdf; https://youtu.be/jnaQIjOz2Dw; https://youtu.be/nZXtwaGh0Z0).Additional information is available at www.asco.org/supportive-care-guidelines.RECOMMENDATIONSThe Expert Panel reiterates its overarching recommendation from the prior guideline that geriatric assessment (GA), including all essential domains, should be used to identify vulnerabilities or impairments that are not routinely captured in oncology assessments for all patients over 65 years old with cancer. Based on recently published RCTs demonstrating significantly improved clinical outcomes, all older adults with cancer (65+ years old) receiving systemic therapy with GA-identified deficits should have GA-guided management (GAM) included in their care plan. GAM includes using GA findings to inform cancer treatment decision-making as well as to address impairments through appropriate interventions, counseling, and/or referrals. A GA should include high priority aging-related domains known to be associated with outcomes in older adults with cancer: physical and cognitive function, emotional health, comorbid conditions, polypharmacy, nutrition, and social support. Clinical adaptation of the GA based on patient population, resources, and time is appropriate.The Panel recommends the Practical Geriatric Assessment as one option for this purpose (https://old-prod.asco.org/sites/new-www.asco.org/files/content-files/practice-patients/documents/2023-PGA-Final.pdf; https://youtu.be/jnaQIjOz2Dw; https://youtu.be/nZXtwaGh0Z0).Additional information is available at www.asco.org/supportive-care-guidelines. RECOMMENDATIONSThe Expert Panel reiterates its overarching recommendation from the prior guideline that geriatric assessment (GA), including all essential domains, should be used to identify vulnerabilities or impairments that are not routinely captured in oncology assessments for all patients over 65 years old with cancer. Based on recently published RCTs demonstrating significantly improved clinical outcomes, all older adults with cancer (65+ years old) receiving systemic therapy with GA-identified deficits should have GA-guided management (GAM) included in their care plan. GAM includes using GA findings to inform cancer treatment decision-making as well as to address impairments through appropriate interventions, counseling, and/or referrals. A GA should include high priority aging-related domains known to be associated with outcomes in older adults with cancer: physical and cognitive function, emotional health, comorbid conditions, polypharmacy, nutrition, and social support. Clinical adaptation of the GA based on patient population, resources, and time is appropriate.The Panel recommends the Practical Geriatric Assessment as one option for this purpose (https://old-prod.asco.org/sites/new-www.asco.org/files/content-files/practice-patients/documents/2023-PGA-Final.pdf; https://youtu.be/jnaQIjOz2Dw; https://youtu.be/nZXtwaGh0Z0).Additional information is available at www.asco.org/supportive-care-guidelines.
引用
收藏
页码:4293 / +
页数:22
相关论文
共 50 条
  • [1] Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Questions and Answers
    Williams, Grant R.
    Hopkins, Judith O.
    Klepin, Heidi D.
    Lowenstein, Lisa M.
    Mackenzie, Amy
    Mohile, Supriya G.
    Somerfield, Mark R.
    Dale, William
    JCO ONCOLOGY PRACTICE, 2023, 19 (09) : 718 - +
  • [2] Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
    Mohile, Supriya G.
    Dale, William
    Somerfield, Mark R.
    Schonberg, Mara A.
    Boyd, Cynthia M.
    Burhenn, Peggy S.
    Canin, Beverly
    Cohen, Harvey Jay
    Holmes, Holly M.
    Hopkins, Judith O.
    Janelsins, Michelle C.
    Khorana, Alok A.
    Klepin, Heidi D.
    Lichtman, Stuart M.
    Mustian, Karen M.
    Tew, William P.
    Hurria, Arti
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) : 2326 - +
  • [3] Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary
    Mohile, Supriya G.
    Dale, William
    Somerfield, Mark R.
    Hurria, Arti
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (07) : 442 - +
  • [4] Systemic Therapy for Melanoma: ASCO Guideline Update
    Seth, Rahul
    Agarwala, Sanjiv S.
    Messersmith, Hans
    Alluri, Krishna C.
    Ascierto, Paolo A.
    Atkins, Michael B.
    Bollin, Kathryn
    Chacon, Matias
    Davis, Nancy
    Faries, Mark B.
    Funchain, Pauline
    Gold, Jason S.
    Guild, Samantha
    Gyorki, David E.
    Kaur, Varinder
    Khushalani, Nikhil I.
    Kirkwood, John M.
    McQuade, Jennifer Leigh
    Meyers, Michael O.
    Provenzano, Anthony
    Robert, Caroline
    Santinami, Mario
    Sehdev, Amikar
    Sondak, Vernon K.
    Spurrier, Gilliosa
    Swami, Umang
    Truong, Thach-Giao
    Tsai, Katy K.
    van Akkooi, Alexander
    Weber, Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (30) : 4794 - +
  • [5] Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update
    Griggs, Jennifer J.
    Bohlke, Kari
    Balaban, Edward P.
    Dignam, James J.
    Hall, Evan T.
    Harvey, R. Donald
    Hecht, Diane P.
    Klute, Kelsey A.
    Morrison, Vicki A.
    Pini, T. May
    Rosner, Gary L.
    Runowicz, Carolyn D.
    Shayne, Michelle
    Sparreboom, Alex
    Turner, Sophia
    Zarwan, Corrine
    Lyman, Gary H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (18) : 2037 - +
  • [6] Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update
    Henry, N. Lynn
    Somerfield, Mark R.
    Dayao, Zoneddy
    Elias, Anthony
    Kalinsky, Kevin
    McShane, Lisa M.
    Moy, Beverly
    Park, Ben Ho
    Shanahan, Kelly M.
    Sharma, Priyanka
    Shatsky, Rebecca
    Stringer-Reasor, Erica
    Telli, Melinda
    Turner, Nicholas C.
    DeMichele, Angela
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (27) : 3205 - +
  • [7] Systemic Therapy for Melanoma: ASCO Guideline Update Q and A
    Sondak, Vernon K.
    Atkins, Michael B.
    Messersmith, Hans
    Provenzano, Anthony
    Seth, Rahul
    Agarwala, Sanjiv S.
    JCO ONCOLOGY PRACTICE, 2024, 20 (02)
  • [8] Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A
    Clark, Amy S.
    Cobain, Erin F.
    Dayao, Zoneddy
    Somerfield, Mark R.
    DeMichele, Angela
    Henry, N. Lynn
    JCO ONCOLOGY PRACTICE, 2022, 18 (12) : 830 - +
  • [9] Systemic Therapy for Melanoma: ASCO Guideline Rapid Recommendation Update
    Seth, Rahul
    Messersmith, Hans
    Funchain, Pauline
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (21) : 2375 - +
  • [10] Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update
    Gordan, John D.
    Kennedy, Erin B.
    Abou-Alfa, Ghassan K.
    Beal, Eliza
    Finn, Richard S.
    Gade, Terence P.
    Goff, Laura
    Gupta, Shilpi
    Guy, Jennifer
    Hoang, Hang T.
    Iyer, Renuka
    Jaiyesimi, Ishmael
    Jhawer, Minaxi
    Karippot, Asha
    Kaseb, Ahmed O.
    Kelley, R. Kate
    Kortmansky, Jeremy
    Leaf, Andrea
    Remak, William M.
    Sohal, Davendra P. S.
    Taddei, Tamar H.
    Woods, Andrea Wilson
    Yarchoan, Mark
    Rose, Michal G.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (15) : 1830 - 1850